The Use of Oritavancin as Consolidation Therapy for Infective Endocarditis Caused by <i>Enterococcus</i> spp.
Oritavancin is emerging as a potential alternative to standard antibiotic regimens in the treatment of infective endocarditis caused by gram-positive bacteria, though evidence remains limited. We hereby report 7 cases of enterococcal endocarditis treated with oritavancin as consolidation therapy, resulting in 6 cures and 1 relapse.
Authors
- Giancarlo Scoppettuolo (ORCID: https://orcid.org/0000-0003-0893-7044)
- Enrica Tamburrini (ORCID: https://orcid.org/0000-0003-4930-426X)
- Flavio Sangiorgi (ORCID: https://orcid.org/0009-0009-7267-8068)
- Francesca Catania
- Eleonora Taddei
- Francesca Giovannenze (ORCID: https://orcid.org/0000-0002-6972-6470)
- Federico Frondizi (ORCID: https://orcid.org/0000-0002-5295-6341)
- Carlo Torti
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-07-30
- DOI
- https://doi.org/10.1093/ofid/ofaf416
- Citations
- 1
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35